#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Oesophageal achalasia Peritoneal mesothelioma malignant Haemolytic uraemic syndrome CDKL5 deficiency disorder Meningococcal immunisation Conjunctivitis allergic Eosinophilic granulomatosis with polyangiitis Follicle centre lymphoma follicular grade I II – III refractory Niemann-Pick disease Giant cell tumour of tendon sheath Biotinidase deficiency Hypersensitivity pneumonitis Hereditary angioedema with C1 esterase inhibitor deficiency PIK3CA-activated mutation Neuroendocrine cell hyperplasia of infancy More trials…

    Learn about Rare Diseases

    Hereditary angioedema with C1 esterase inhibitor deficiency – Life with Disease Hereditary neuropathic amyloidosis Lysosomal storage disorder – Treatment Pituitary-dependent Cushing’s syndrome – Basic Information Erdheim-Chester disease – Treatment Toxic epidermal necrolysis Hereditary ataxia – Trials in Disease Lymphangioma – Basic Information Ehlers-Danlos syndrome – Life with Disease Crigler-Najjar syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ANUMIGILIMAB Glenzocimab RIKKUNSHITO Dirocaftor Lonvoguran Ly3484356 TAGRAXOFUSP Tovinontrine Elvn-002-1 Teicoplanin Ttf-Ngr Gt005 ZALFERMIN Tigecycline Cefaclor Cldn6 Car-T(A) Digitoxin Amlodipine Besilate Alternaria Alternata Extract ULVIPRUBART More therapies…

    Learn about Your Condition

    Tendon rupture Bronchiectasis Adenovirus infection Klinefelter's syndrome Haemorrhage Glomerulonephritis chronic Graft infection Rhinitis allergic Prostate cancer recurrent Osteomyelitis Alport's syndrome Trisomy 21 Adrenogenital syndrome Neonatal hyperglycaemia Microscopic polyangiitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Antoine Lacassagne

Centre Antoine Lacassagne

33 Avenue De Valombrose, Nice, 06189, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Oxaliplatin, Nivolumab, and Trifluridine/Tipiracil for Patients with Advanced Gastric, Esophageal, or Gastroesophageal Junction Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Gastric cancer
    • Gastric cancer recurrent
    • Gastrooesophageal cancer
    Investigated Drugs:
    • Capecitabine
    • Fluorouracil
    • Folinic Acid
    France

  • Study Comparing Two Treatment Strategies for Intermediate-Risk Thyroid Cancer Using Sodium Iodide (131I) in Patients with Post-Surgery Evaluation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Follicular thyroid cancer
    • Papillary thyroid cancer
    • Thyroid cancer
    Investigated Drugs:
    • Sodium Iodide (131I)
    France

  • Study on the Effectiveness of Doxorubicin, Ifosfamide, and Dacarbazine in High-Risk Soft Tissue Sarcoma Patients

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Dacarbazine Citrate
    • Doxorubicin
    • Ifosfamide
    France

  • Study on the Effectiveness of Chemotherapy with Folinic Acid, Fluorouracil, and Irinotecan for Patients with Stage III Colon Cancer After Surgery

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Bevacizumab
    • Fluorouracil
    • Folinic Acid
    France

  • Study on Tucatinib, Capecitabine, and Trastuzumab for Patients with HER2-Positive Breast Cancer and Leptomeningeal Metastases

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Capecitabine
    • Trastuzumab
    • Tucatinib
    France

  • Long-term Safety Study of Niraparib for Patients with Advanced Ovarian, Breast, or Prostate Cancer Who Completed a Previous Niraparib Study

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Niraparib Tosilate Monohydrate
    Austria France Germany Italy Romania Spain

  • Study on Contact X-ray Brachytherapy with Capecitabine for Rectal Cancer Preservation in Adults with Intermediate Stage Rectal Adenocarcinoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Rectal adenocarcinoma
    Investigated Drugs:
    • Capecitabine
    • Fluorouracil
    • Folinic Acid
    France

  • Study on the Effects of Acetylsalicylic Acid and Atorvastatin in Patients with Castration-Resistant Prostate Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Atorvastatin
    Czechia France

  • Study of Fluoroestradiol F-18 and Biomarkers for Women with ER-Positive HER2-Negative Metastatic Breast Cancer After CDK4/6 Inhibitor Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    Investigated Drugs:
    • Fluoroestradiol F-18
    France

  • Study on Olaparib for Patients with p53abn Endometrial Cancer After Chemoradiation Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Endometrial cancer
    Investigated Drugs:
    • Olaparib
    France
Previous Page
1 … 8 9 10 11 12 … 28
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!